Bupivacaine RCT- Bupivacaine as Adjuvant for Post-operative Pain in Mohs micrographic surgery

Bupivacaine RCT- Bupivacaine as Adjuvant for Post-operative Pain in Mohs micrographic surgery
Enrolling By Invitation
18 years - 99 years
All
Phase N/A
100 participants needed
1 Location

Brief description of study

The research study is being conducted to find the best ways to reduce pain after Mohs surgery. The research team hopes to learn if adding additional numbing medication at the end of surgery will help reduce pain afterwards.

Penn Medicine patients having Mohs surgery will be invited to participate in the research trial if they are eligible.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: surgery,mohs
  • Age: 18 years - 99 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 843724
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research